Gritstone bio falls after filing for bankruptcy

Gritstone bio

10/10/2024 11:40

(Updates)
    ** Shares of drug developer Gritstone bio  GRTS.O  fall 37%
to 13 cents premarket
    ** Company files for Chapter 11 bankruptcy
    ** GRTS lists both estimated assets and liabilities at $100
million to $500 million - court filing
    ** "During its financial restructuring process, Gritstone
intends to operate in the ordinary course and remains committed
to advancing its clinical programs" - company
    ** On Oct. 1, GRTS shares closed 62.1% lower after it
reported mixed interim data from a mid-stage study of its
experimental vaccine for colorectal cancer patients
    ** Up to last close, stock down 90.3% YTD

 (Reporting by Puyaan Singh)
 ((Puyaan.Singh@thomsonreuters.com;))